Burst Expert Illustrations & Commentaries™: Management Strategies for Refractory Ascites
June 28, 2022
June 28, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Mallinckrodt Pharmaceuticals.
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
- Nurses — 0.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed toward health care providers serving patients with cirrhosis, including hepatologists, gastroenterologists, nephrologists, critical care specialists, physician assistants, and nurses. Other health care professionals will also be invited to participate.
Cirrhosis is a result of longstanding fibrosis, and can result in various negative sequelae including ascites. Ascites is the most common complication related to cirrhosis and is associated with increased morbidity and mortality. Refractory ascites occurs in approximately 5%-10% of all patients with cirrhosis and ascites and is associated with survival of only 50% at 6 months.
This online educational activity is designed to provide expert commentary on the pathophysiology and treatment of refractory ascites. These will be presented in a multimedia format, including audio interviews with an expert thought leader and animated videos integrated into text-based elements.
Upon completion of this activity, participants should be better able to:
- Explain various factors that contribute to the pathophysiology of refractory ascites
- Formulate a treatment plan for patients with refractory ascites based on current evidence
Elizabeth Verna, MD, MSc
Frank Cardile Associate Professor of Medicine
Director of Hepatology Research
Division of Digestive and Liver Diseases
Department of Medicine
Columbia University Irving Medical Center
New York, NY
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.
- Elizabeth Verna, MD, MSc
- Grant/Research Support: Salix Pharmaceuticals
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.